Cleerly

What is Cleerly?

Cleerly is an AI-driven platform that quantifies and assesses coronary artery disease and delivers clinically actionable insights through a web-based solution. It measures plaque volume, composition, length and location, and evaluates stenosis severity in 2D and 3D. Cleerly serves healthcare providers, payors and patients.

Key capabilities of Cleerly

• Cleerly Plaque Analysis: quantifies plaque volume, composition, length and location
• Stenosis evaluation: severity in 2D and 3D views
• Cleerly ISCHEMIA: workflow for the likely presence of ischemia
• Cleerly COMPARE: compares studies over time
• Web-based delivery: runs through a browser-based solution
• Clinical reports: actionable results for physicians and patients

How Cleerly works

A coronary CT angiography scan is submitted to the web platform, where AI quantifies plaque and stenosis. Cleerly ISCHEMIA adds a diagnostic ischemia assessment, and clinicians review the output to guide care. In the CREDENCE trial, the vendor says Cleerly ISCHEMIA showed higher diagnostic accuracy and area under the curve than FFRCT and stress testing.

Who uses Cleerly?

Cardiologists, imaging centers and health systems use Cleerly. In an analysis of the PACIFIC trial, Cleerly ISCHEMIA was noted as the only non-invasive ischemia test prognostic of future MACE events.

Cleerly pricing

Cleerly does not publish pricing. Contact the vendor for terms.

Cleerly alternatives

Cleerly is compared with Us2.ai, Anumana and Eko Health. Us2.ai automates echocardiography measurements, Anumana applies AI to ECGs and Eko Health uses digital stethoscopes.